Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NSC-87877 |
| Synonyms | |
| Therapy Description |
NSC-87877 is an inhibitor of Shp2, which may result in inhibition of Erk1/2 activation and decreased cell proliferation (PMID: 16717135, PMID: 30388134). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NSC-87877 | NSC87877|NSC 87877 | NSC-87877 is an inhibitor of Shp2, which may result in inhibition of Erk1/2 activation and decreased cell proliferation (PMID: 16717135, PMID: 30388134). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|